Protein labeling is a process in biological research that uses molecular labels to create covalent bonds with the protein of interest. This helps in the detection and purification of the labeled protein and/or its binding associates. The process is carried out with the use of different labels such as, biotin, reporter enzymes, monoclonal antibodies, fluorophores, radioactive isotopes, and other tags. Specific labels are used to target a particular protein or nucleotide sequence and the labeling strategy is carefully selected and completed for each application. This process is helpful to identify proteins in tissues, cells, samples, and biochemical assays. The increase in healthcare and R&D expenditure and progress in proteomics research primarily drive the protein labeling market.
This market is estimated to reach $5,350 million by 2022 from $2,002 million in 2015, growing at a significant CAGR of 14.9% during the forecast period. Moreover, government investments on healthcare and R&D on the increase in the use of proteomics, and other applications such as diagnostics and therapeutics are expected to drive the market. However, lack of skilled professionals and accelerated market consolidation is expected to restrict the market growth.
The growth in competition has led to collaborations and product launch by major players in the protein labeling market. For instance, in September 2016, Kaneka Corporation’s subsidiary, Eurogentec S.A. signed an agreement with Koram Biotech Corp. (KBC), one of the largest life science reagent and services companies in South Korea, to be the new distributor for its products. This collaboration has helped Kaneka to make a smooth entry in the South Korean market. Likewise, in June 2016, F. Hoffmann-LA Roche AG (Roche) launched a new product, Cobas E 801 module, a high-volume testing immunoassay solution that had high flexibility and continuous operation, which saves time and reduces the amount of waste generated during the process.
The global protein labeling market report provides an extensive analysis of the current market trends and future estimations prevailing in the market.
The market estimations from 2014 to 2022 are based on high-end analysis of the key developments.
The market scenario is comprehensively analyzed with respect to the application, product type, labeling method, and end users.
Recent developments and key manufacturers are listed and analyzed to understand the competitive market scenario.
In-depth analysis, based on geography provides an understanding of the regional market, which assists in strategic business planning.
KEY MARKET SEGMENTS
By Labeling Method
In Vitro Labeling
In Vivo Labeling
BY PRODUCT TYPE
By End User
Hospitals and Diagnostic Centers
Rest of Europe
Rest of Asia-Pacific
Republic of South Africa
Rest of LAMEA
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PATENT ANALYSIS
3.3.1. Patent analysis, by year
3.3.2. Patent analysis, by country
3.4. TOP IMPACTING FACTORS
126.96.36.199. Rise in healthcare expenditure
188.8.131.52. Increase in R&D investments
184.108.40.206. Growth in proteomics research
220.127.116.11. Lack of skilled professionals
18.104.22.168. Training the professionals
22.214.171.124. Greater potency with reduced costs and increasing affordability
CHAPTER 4 GLOBAL PROTEIN LABELING MARKET, BY LABELING METHOD
4.1.1. Market size & forecast
4.1.2. In vitro labeling
126.96.36.199. Market size & forecast
188.8.131.52. Nanoparticle labeling
184.108.40.206.1. MARKET SIZE & FORECAST
220.127.116.11. Site-specific Labeling
18.104.22.168.1. MARKET SIZE & FORECAST
22.214.171.124.1. MARKET SIZE & FORECAST
126.96.36.199. Co-translational labeling
188.8.131.52.1. MARKET SIZE & FORECAST
184.108.40.206. Enzymatic Labeling
220.127.116.11.1. MARKET SIZE & FORECAST
4.1.3. In vivo labeling
18.104.22.168. Market size & forecast
22.214.171.124. Radioactive labeling
126.96.36.199.1. MARKET SIZE & FORECAST
188.8.131.52. Photoreactive labeling
184.108.40.206.1. MARKET SIZE & FORECAST
4.1.4. Bioorthogonal labeling
220.127.116.11. Market size & forecast
CHAPTER 5 GLOBAL PROTEIN LABELING MARKET, BY APPLICATION
5.1.1. Market size and forecast
5.1.2. Cellbased assays
18.104.22.168. Key market trends
22.214.171.124. Key growth factors and opportunities
126.96.36.199. Market size and forecast
5.1.3. Fluorescence microscopy
188.8.131.52. Key market trends
184.108.40.206. Key growth factors and opportunities
220.127.116.11. Market size and forecast
5.1.4. Mass spectrometry
18.104.22.168. Key market trends
22.214.171.124. Key growth factors and opportunities
126.96.36.199. Market size and forecast
5.1.5. Immunological techniques
188.8.131.52. Key market trends
184.108.40.206. Key growth factors and opportunities
220.127.116.11. Market size and forecast
5.1.6. Protein microarray
18.104.22.168. Key market trends
22.214.171.124. Key growth factors and opportunities
126.96.36.199. Market size and forecast
CHAPTER 6 GLOBAL PROTEIN LABELING MARKET, BY PRODUCT TYPE
6.1.1. Market size & forecast
6.2.1. Market size & forecast
6.3.1. Market size & forecast
188.8.131.52. Market size & forecast
6.3.3. Monoclonal antibodies
184.108.40.206. Market size & forecast
220.127.116.11. Market size & forecast
18.104.22.168. Market size & forecast
6.3.6. Other Reagents
22.214.171.124. Market size & forecast
6.4.1. Market size & forecast
CHAPTER 7 GLOBAL PROTEIN LABELING MARKET, BY END USERS
7.1.1. Market size & forecast
7.2. RESEARCH LABORATORIES
7.2.1. Market size & forecast
7.3. HOSPITALS AND DIAGNOSTIC CENTERS
7.3.1. Market size & forecast
7.4.1. Market size & forecast
CHAPTER 8 GLOBAL PROTEIN LABELING MARKET, BY GEOGRAPHY
8.1.1. Market size & forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size & forecast
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size & forecast
8.3.7. Rest of Europe
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size & forecast
8.4.8. Rest of Asia-Pacific
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size & forecast
8.5.5. Republic of South Africa
8.5.6. Rest of LAMEA
CHAPTER 9 COMPANY PROFILES
9.1. GENERAL ELECTRIC COMPANY
9.1.1. Company overview
9.1.2. Operating business segments
9.1.3. Business performance
9.1.4. Key strategic moves & developments
9.2. PERKINELMER, INC.
9.2.1. Company overview
9.2.2. Operating business segments
9.2.3. Business performance
9.2.4. Key strategic moves & developments
9.3. THERMO FISHER SCIENTIFIC, INC.
9.3.1. Company overview
9.3.2. Operating business segments
9.3.3. Business performance
9.3.4. Key strategic moves & developments
9.4. MERCK & CO., INC.
9.4.1. Company overview
9.4.2. Operating business segments
9.4.3. Business performance
9.4.4. Key strategic moves & developments
9.5. F. Hoffmann-La Roche AG
9.5.1. Company overview
9.5.2. Operating business segments
9.5.3. Business performance
9.5.4. Key strategic moves & developments
9.6. KANEKA CORPORATION
9.6.1. Company overview
9.6.2. Operating business segments
9.6.3. Business performance
9.6.4. Key strategic moves & developments
9.7. PROMEGA CORPORATION
9.7.1. Company overview
9.7.2. Operating business segments
9.7.3. Business performance
9.7.4. Key strategic moves & developments
9.8. LI-COR, INC.
9.8.1. Company overview
9.8.2. Operating business segments
9.8.3. Business performance
9.8.4. Key strategic moves & developments
9.9. NEW ENGLAND BIOLABS, INC.
9.9.1. Company overview
9.9.2. Operating business segments
9.9.3. Business performance
9.9.4. Key strategic moves & developments
9.10. SERACARE LIFE SCIENCES, INC.
9.10.1. Company overview
9.10.2. Operating business segments
9.10.3. Business performance
9.10.4. Key strategic moves & developments
Protein labeling is an effective technique to study protein structure, function, and functioning of genes. The global protein labeling market has become prominent due to increase in expenditure on R&D, escalation in proteomics research, and rise in the healthcare expenses. Moreover, the launch of new technologies has boosted this market.
Protein labeling technique is a secondary research tool for proteomic analysis, and is used for research and diagnostic purposes in biotechnology and pharmaceuticals industries. Moreover, with the rise in the prevalence of chronic diseases such as cancer, the need for prevention, diagnosis, and treatment of such diseases is on the rise. Consequently, the demand for such techniques is anticipated to increase. Alternatively, lack of skilled professionals, limited applications of protein labeling products along with high costs of reagents, kits, and other protein labeling services are the key factors that could impede the market growth.
Amongst the labeling methods, the in vivo labeling segment dominates the market with more than half of the global protein labeling market in 2015. This is mainly attributed to ease of availability of products and reagents and the stability of this method. However, bioorthogonal labeling segment is expected to be thefastest growing segment. This is attributed to the fact that this method of proteins labeling can be carried out in living cells without hindering the biochemical functioning of the cell.
By product types, the reagents segment dominated the global proteinlabelling market. Reagents accounted for about 60% share in 2015 and are frequently used in different protein labeling procedures, from sample preparation to washing and incubation. As the objective of every research is different, the researcher cannot use conventional products for different methodologies. Thus, the growth in demand for customized protein labeling services segment have lead it to become the fastest growing segment during the forecast period.
Key findings of the Protein Labeling Market Study:
Nanoparticle labeling segment is estimated to exhibit a CAGR of 17.4%, among in vitro labeling.
Fluorescence Microscopy segment will exhibit a CAGR of 16.1% in LAMEA region.
Research laboratories segment holds two-thirds of the share in the end-user protein labeling market.
Photoreactive labeling segment for in vivo protein labeling is projected to be the fastest growing segment from 2016 to 2022.
Mexico was the smallest economy market in 2015, and is projected to grow at a CAGR of 15.7% through 2022.
Based on geography, North America generated the highest revenue in 2015, accounting for the majority of the share of global protein labeling market, due to various technological advancements, rise in R&D investments, and surge in demand for protein labeling products. Furthermore, North America is estimated to continue to dominate the world market, owing to rise in technological innovations andsignificant rise in funding. The Asia-Pacific region is expected to be the fastest growing segment, owing to the increased demands of emerging economies such as Japan and China and rise in healthcare expenditure.
The key developmental strategies adopted by leading market players are product launches, collaborations, and partnerships. The prominent market players profiled in the report include General Electric Company, Kaneka Corporation, LI-COR, Inc., Merck & Co., Inc., New England Biolabs, Inc., PerkinElmer, Inc., Promega Corporation, F. Hoffmann-LA Roche AG, Seracare Life Sciences, Inc., and Thermo Fisher Scientific, Inc.
- General Electric Company
- Kaneka Corporation
- LI-COR, Inc.
- Merck & Co., Inc.
- New England Biolabs, Inc.
- PerkinElmer, Inc.
- Promega Corporation
- F. Hoffmann-LA Roche AG
- Seracare Life Sciences, Inc.
- Thermo Fisher Scientific, Inc.